🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Adenocarcinoma Esophagus

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma NCT00288119n/a10 sites📍 Baltimore📍 Rochester📍 St Louis Case Western Reserve University · Tests: Balloon Capsule Device, Endoscopy Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer NCT06962137Phase 26 sites📍 Antwerp📍 Brussels📍 Brussels Universitaire Ziekenhuizen KU Leuven · Tests: zolbetuximab, Retrospective cohort, no intervention Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms NCT06687603NA5 sites📍 Aurora📍 Baltimore📍 Chapel Hill Case Comprehensive Cancer Center · Tests: EsoCheck, EsoGuard A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893NA2 sites📍 San Francisco📍 Walnut Creek University of California, San Francisco · Tests: Radiation Therapy (RT) Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry NCT00574327n/a1 site📍 Kansas City Midwest Biomedical Research "Less-is-more in Barrett-surveillance" Care Evaluation of Barrett's Patients With Low-Risk in Whom Endoscopic Surveillance is Stopped. The BLISS Project. NCT06803147n/a1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Discontinued endoscopic surveillance Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies NCT03539822Phase 1, Phase 22 sites📍 Westwood📍 Pittsburgh Anwaar Saeed · Tests: Cabozantinib, Durvalumab, Tremelimumab Lucid Registry Study NCT05965999n/a1 site📍 Lake Forest Lucid Diagnostics, Inc. · Tests: EsoCheck®, EsoGuard® Evaluation of Seismocardiography(SCG) for Assessing Fitness and Predicting Outcomes in Oesophageal Cancer Surgery NCT07159711n/a4 sites📍 Guildford📍 London📍 London Guy's and St Thomas' NHS Foundation Trust · Tests: Seismofit Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma NCT06340711Phase 22 sites📍 New York📍 Philadelphia Weill Medical College of Cornell University · Tests: OBP-301, Pembrolizumab Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors NCT04900818Phase 121 sites📍 Orange📍 Aurora📍 Layfayette I-Mab Biopharma US Limited · Tests: TJ033721 (givastomig), TJ033721 (givastomig) , nivolumab, chemotherapy, TJ033721 (givastomig), chemotherapy, TJ033721 (… mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma NCT05677490Phase 3798 sites📍 Birmingham📍 Anchorage📍 Anchorage Alliance for Clinical Trials in Oncology · Tests: Fluorouracil, Leucovorin Calcium, Oxaliplatin, Irinotecan, Nivolumab A Multicenter Prospective Cohort Study Comparing Random Biopsies Versus Wide-Area Transepithelial Brush-Sampling (WATS) for Surveillance of Barrett's Esophagus, the WATS-EURO2 Study NCT05642338n/a1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: WATS3D Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus) NCT05177133Phase 28 sites📍 Amsterdam📍 Amsterdam📍 Eindhoven Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Capecitabine, Oxaliplatin, Retifanlimab A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma NCT07818018Phase 1, Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Intratumoral 2141-V11, Nivolumab, Fluoropyrimidine Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors NCT06005493Phase 1, Phase 225 sites📍 Jacksonville📍 Rochester📍 New York AstraZeneca · Tests: AZD5863, AZD2936 A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma NCT06623396Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: M28z1XXPD1DNR CAR Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma NCT07222657Phase 21 site📍 Weston Case Comprehensive Cancer Center · Tests: Standard of care chemotherapy, LNSC Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype NCT06532734n/a3 sites📍 Denver📍 Denver📍 Denver Denver Health and Hospital Authority · Tests: EsoGuard Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus NCT06732388Phase 26 sites📍 Kansas City📍 Ann Arbor📍 St Louis National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Endoscopic Procedure, Itraconazole, Placebo Administration Obeticholic Acid for Prevention in Barrett's Esophagus NCT04939051Phase 28 sites📍 Kansas City📍 Ann Arbor📍 St Louis National Cancer Institute (NCI) · Tests: Biospecimen Collection, Esophageal Biopsy, Esophagogastroduodenoscopy, Liver Ultrasonographic Elastography, Obeticholic… NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer NCT04615013Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Capecitabine, Carboplatin, Docetaxel, Fluorouracil, Hafnium Oxide-containing Nanoparticles NBTXR3 Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction NCT06161818Phase 210 sites📍 Eindhoven📍 Leeuwarden📍 Tilburg Erasmus Medical Center · Tests: FLOT-CROSS or CROSS-FLOT Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples NCT06071845NA5 sites📍 Scottsdale📍 Jacksonville📍 Chicago Mayo Clinic · Tests: Cytosponge Procedure, Endoscopic Assessment Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma NCT05651594Phase 21 site📍 Buffalo Roswell Park Cancer Institute · Tests: Biopsy, Biospecimen Collection, Computed Tomography, Fluorouracil, Leucovorin Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06) NCT06469944Phase 1, Phase 250 sites📍 Tucson📍 Los Angeles📍 Louisville Merck Sharp & Dohme LLC · Tests: Pembrolizumab, Sacituzumab Tirumotecan (sac-TMT), Capecitabine, Leucovorin, Levoleucovorin Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy NCT06687876Phase 22 sites📍 Amsterdam📍 Amsterdam Amsterdam UMC, location VUmc · Tests: Metformin A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer NCT06523374NA9 sites📍 Edegem📍 Wilrijk📍 Ghent University Hospital, Antwerp · Tests: Endoscopic brush cytology A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors NCT06657144Phase 130 sites📍 Tucson📍 Duarte📍 Aurora Coherus Oncology, Inc. · Tests: CHS-114, Toripalimab, 5 Fluorouracil, Cisplatin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy